During the past decade, Seattle Cancer Care Alliance at EvergreenHealth conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 28 clinical trials were completed, i.e. on average, 90.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 23 clinical trials were completed. i.e. 287.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seattle Cancer Care Alliance at EvergreenHealth" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Cancer Care Alliance at EvergreenHealth" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Cancer Care Alliance at EvergreenHealth" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Seattle Cancer Care Alliance at EvergreenHealth" in a lesser frequency.

Most popular intervention types in "Seattle Cancer Care Alliance at EvergreenHealth" are "Drug" (44 trials), "Other" (39 trials), "Biological" (21 trials), "Procedure" (12 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (13 trials), "Cisplatin" (8 trials), "Docetaxel" (8 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Cancer Care Alliance at EvergreenHealth" are 44 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Seattle Cancer Care Alliance at EvergreenHealth". undefined are not yet recruiting, 10 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Seattle Cancer Care Alliance at EvergreenHealth, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Cancer Care Alliance at EvergreenHealth, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".